ArticleCardiovascular diabetology2019

Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study.

T M Hommels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.